Literature DB >> 15260272

Smear examination of two specimens for diagnosis of pulmonary tuberculosis in Tiruvallur District, south India.

P G Gopi1, R Subramani, N Selvakumar, T Santha, S I Eusuff, P R Narayanan.   

Abstract

SETTINGS: A general hospital and three peripheral health institutions (PHI) in Tiruvallur District, south India.
OBJECTIVE: To validate the case detection strategy for diagnosis of pulmonary tuberculosis by smear microscopy of two sputum specimens versus three.
METHODS: In the Revised National Tuberculosis Control Programme (RNTCP), three smears from every symptomatic patient attending the PHI were examined for acid-fast bacilli (AFB) by Ziehl-Neelsen (ZN) microscopy. The data from the Tuberculosis Laboratory Registers from the above centres were analysed.
RESULTS: Of 7843 chest symptomatics who had provided three sputum specimens for examination, 895 (11.4%) were smear-positive on at least two specimens. Examination of two specimens--first spot and early morning specimens (837, 93.5%) or early morning and second spot specimens (843, 94.2%)--yielded the highest number of cases.
CONCLUSION: The examination of two sputum smears (one spot and an early morning) is as effective as examination of three smears.

Entities:  

Mesh:

Year:  2004        PMID: 15260272

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  Determining the burden of tuberculosis in Eritrea: a new approach.

Authors:  Mineab Sebhatu; Bahlbi Kiflom; Melles Seyoum; Nuredin Kassim; Tesfazion Negash; Andeberhan Tesfazion; Martien W Borgdorff; Marieke J van der Werf
Journal:  Bull World Health Organ       Date:  2007-08       Impact factor: 9.408

2.  Diagnosis and treatment of pulmonary tuberculosis in one day: Way forward for END TB Strategy 2015.

Authors:  Gourahari Pradhan; Manoranjan Pattnaik; Hemanta Kumar Sethy; Jyoti Patnaik; Thitta Mohanty; Pradeep Kumar Giri
Journal:  J Family Med Prim Care       Date:  2019-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.